Is there anything that could prevent pro 140 from being approved? The results look good, minimal side effects, and so on. Apparently the supporting data looks good as well. But can we as a group think of any reason that the phase 3 might fail or the FDA wouldn't approve pro 140 as an adjunct therapy? I'm usually a realist and play devils advocate as well, but things appear too good to be true.
It seems everyone has a lot of hopes on a Gilead buyout. there are other HIV medication makers , and like Gilead , their patents are going or have gone generic. Generic is just as much as a revenue killer imo as Pro 140 could be.
News 
Market Data 
Discover 
